TECR - TechCare Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1400
0.0000 (0.00%)
At close: 9:43AM EST
Stock chart is not supported by your current browser
Previous Close0.1400
Open0.1400
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.1400 - 0.1400
52 Week Range0.0401 - 0.7500
Volume422
Avg. Volume3,326
Market Cap4.65M
Beta (3Y Monthly)3.90
PE Ratio (TTM)N/A
EPS (TTM)-0.06
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TechCare Appoints Osnat Philipp, Former Lumenis, P&G and Teva Pharmaceuticals Executive, as Chief Executive Officer of Novomic
    PR Newswire5 days ago

    TechCare Appoints Osnat Philipp, Former Lumenis, P&G and Teva Pharmaceuticals Executive, as Chief Executive Officer of Novomic

    NEW YORK, Jan. 15, 2019 /PRNewswire/ -- TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced that it appointed Osnat Philipp, former Lumenis, P&G and Teva Pharmaceuticals executive, as Chief Executive Officer of its wholly owned subsidiary, Novomic Ltd.

  • PR Newswire8 months ago

    TechCare Submits Patent Application for Breakthrough Smart Capsule™ Technology, Paving the Way for Novel Health, Wellness and Beauty Solutions

    NEW YORK, May 31, 2018 /PRNewswire/ -- TechCare Corp. (TECR) ("TechCare"), today announced that following intensive R&D and investments, it has expanded its existing IP portfolio with a recently submitted patent application of its Smart Capsule™ technology. Building upon its existing patents and know-how, the new Smart Capsule™ technology enables the vaporization of two or more compounds simultaneously, thus expanding the variety of applications while yielding superior performance, usability and ease-of-use.

  • PR Newswire9 months ago

    TechCare Launches Its Novokid Lice Treatment Products Line in Super Pharm, Israel's Largest Drugstore Chain

    NEW YORK, May 3, 2018 /PRNewswire/ -- TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced it will launch its Novokid Lice Treatment Products Line in Super Pharm, Israel's largest and leading drugstore chain. The launch will take place following the signing of a distribution agreement with Meditrend, a leading distributor in Israel, specializing in health and wellness products.

  • PR Newswirelast year

    TechCare Announces Closing of $1.8 Million Funding

    TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced it has closed an $1.8 million round of funding. Mr. Yemini has long been a pioneer in tech and consumer goods, having founded ZAG Industries Ltd. (sold to Stanley Black & Decker), Polymer Logistics and Hydro Industries Ltd. With an MBA from Tel Aviv University and over 35 years' experience as an entrepreneur and business leader, his $400,000 is a follow-up investment.

  • PR Newswirelast year

    TechCare Signs its First European Distribution Agreement for Novokid Lice Treatment Device, with MWMedical B.V. in the Netherlands

    TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced it has signed its first distribution agreement with MWMedical B.V., a leading distributor of medical devices in the Netherlands, for TechCare's Novokid lice treatment device, which addresses a $1.8 billion market globally, and a European market estimated to exceed $500 million. The multi-year agreement grants the distributor exclusive distribution rights in the Netherlands in consideration of minimum purchase commitments. The distributor has already placed its first order of Novokid's products, 2,500 kits, which will be available in the Netherlands beginning                           in mid-February.